Financials

Company Profile

IMV Inc. is a Canada-based company. The Company has sold all of its assets. It is not engaged in any business operations.

Employees

Sector

24/04/24	OPEC excited about Namibia partnership, offers support	RE
16/03/23	IMV Inc., Q4 2022 Earnings Call, Mar 16, 2023
11/11/22	IMV Inc., Q3 2022 Earnings Call, Nov 11, 2022
11/08/22	IMV Inc., Q2 2022 Earnings Call, Aug 11, 2022
29/06/22	IMV Inc. - Shareholder/Analyst Call

04/09/23	IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets	AQ
13/06/19	IMV Inc. : to Present at Two Upcoming Investor Conferences	BU
12/06/19	Imv : New Phase 2 Clinical Trial Results Continue to Demonstrate Potential Clinical Benefit of IMV’s DPX-Survivac in Combination with Merck’s Keytruda in Patients with DLBCL	BU

Manager	Title	Age	Since
Stéphane Fiset CTO	Chief Tech/Sci/R&D Officer	-	-
Tracy Sherren SEC	Corporate Secretary	60	-
Marie-Eve Charrois LAW	General Counsel	-	-

Director	Title	Age	Since
Markus Warmuth BRD	Director/Board Member	55	05/11/2018
Michael Bailey CHM	Chairman	60	30/04/2022
Michael Kalos BRD	Director/Board Member	64	10/05/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IMV INC	+11.37%	+4.00%	-	-	14
IQM QUANTUM COMPUTERS OYJ	+6.75%	0.00%	-	-	3.67B
SECURITIZE CORP.	-11.54%	-16.31%	-1.07%	-	1.86B
EINRIDE AB	+1.78%	+24.67%	-	-	1.2B
CHURCHILL CAPITAL CORP XI	-9.84%	+5.00%	-	-	959M
CHURCHILL CAPITAL CORP VII	-0.30%	-.--%	-.--%	-3.20%	915M
PRIME BEING CORP.	-35.29%	-.--%	+44.74%	+391.07%	797M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	0.00%	+0.20%	-	-	643M
CENTIEL AG	-1.62%	-16.94%	+285.30%	-69.45%	615M
ACC AVIATION HOLDINGS LTD.	-1.57%	-.--%	+1,150.00%	+284.02%	624M
Average	-4.03%	+0.59%	+295.79%	+150.61%	1.25B
Weighted average by Cap.	-3.04%	-0.07%	+192.42%	+150.20%